Drug intelligence / Profile preview

Cleoderm

Development stage
Unknown
Lead developer
Fagron
Modality
Small Molecules, Peptides
Administration
Topical
01

Overview

Cleoderm is a functional topical cream vehicle and compounding base developed by Fagron for personalized dermatological treatments. While primarily serving as a pharmaceutical excipient for compounding active pharmaceutical ingredients (APIs), it possesses inherent functional properties including the reduction of sebum production, inhibition of *Cutibacterium acnes* proliferation, and anti-inflammatory and antioxidant effects. The formulation is plant-based, featuring *Cleome gynandra* L. leaf extract as a key constituent, alongside hyaluronic acid, palmitoyl tripeptide-8, bisabolol, tocopheryl acetate, and a blend of eight functional oils. It is specifically designed for use in treating inflammatory skin conditions such as acne vulgaris, rosacea, dermatitis, and hyperpigmentation, providing a gentle and effective base for facial applications.

Brand names
CleodermCleoderm Clarifying Cream
Other names
Cleoderm-Fragon-topical cream vehicle-pharmaceutical excipient-compounding vehicle-topical-dermatologic conditions (as formulation base)

Beyond the preview

Go deeper on Cleoderm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cleoderm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call